Summary In the present study, the effects of vitamins E and C on the levels of neuro transmitters and acetylcholinesterase activity in the brains of rats treated with scopo lamine, an inducer of dementia, were examined. Fifty male Sprague-Dawley rats at the age of 5 wk were divided into five groups after 1 wk of adaptation and fed five different diets for 6 wk: a no-scopolamine group, which was a scopolamine-untreated group fed only a basal diet; a scopolamine-treated group fed a basal diet; a vitamin E-supplemented scopolamine treated group; a vitamin C-supplemented scopolamine-treated group; and a vitamins E and C-supplemented scopolamine-treated group. Scopolamine was twice administered by in traperitoneal injection (300mg/kg, body weight), 3 d and 20min prior to sacrifice. Brain acetylcholinesterase activity was markedly reduced by scopolamine injection. However, the supplementation of vitamins E and C in the diet significantly increased the reduced brain acetylcholinesterase activity up to the level of the scopolamine-untreated group. Brain sero tonin concentration in the vitamin C-supplemented scopolamine-treated group was signifi cantly higher than that in the scopolamine-treated group. However, there were no signifi cant differences in brain dopamine and norepinephrine concentrations among all groups. In conclusion, supplementation with vitamin E and/or vitamin C might be useful in main taining brain acetylcholinesterase activity at the normal level and serotonin concentration for some extent under the condition to induce dementia by scopolamine administration.
Recently, the elderly population has increased be cause of increased life expectancy. In turn, dementia, a neurodegenerative disease in older adults, has become a major health concern in modern societies. In America, the prevalence of dementia is approximately 14% in the elderly over 65 years of age (1) , and the rates double every 5.1 y as age increases (2) . In Korea, there are an estimated 200,000 dementia patients, and this number is expected to reach 500,000 by 2020 (3) . Thus the search for measures to prevent dementia has become an urgent one.
Dementia is a progressive and degenerative mental disease resulting in the impairment of memory, think ing, and behavior. Age (4), gender (5) , family history (6) , and brain damage (7) have been proposed to be risk factors for dementia. Although the mechanism of the development of dementia is unknown, it has been pos tulated that free radicals may play a role. Free radicals formed by oxidative stress promote the peroxidation re sue in vitro, the more added, the fewer lipid peroxides produced (17, 18) . Deana et al. (19) found that brain acetylcholinesterase and catecholamine levels were re duced in vitamin C deficiency. In another study, damage induced by 3,4-methylene dioxy-methamphetmaine (MDMA) (20) and 1-methyl-4-phenyl-1,2,3,6-tetra hy dropyridine (21) to the serotoninergic and dopaminer gic nerve systems was prevented by vitamin C supple mentation. Besides these findings, vitamins E and C levels in the plasma (22) and cerebrospinal fluid of Alzheimer's pa tients (23) were lower than those in normal subjects.
As mentioned above, vitamins E and C could lead to favorable effects on neurotransmitter metabolism in the normal states. In the present study, therefore, we inves tigated whether supplementation of vitamin E and/or vitamin C can maintain normal brain neurotransmitter status under the condition of induced dementia. 
RESULTS
Body weight gain and brain weight in all the experi mental groups are shown in Table 3 . Compared with the N-Sc group, the body weight gains of all the scopo lamine-treated groups were significantly lower (p< 0.05). There was no significant difference, however, in body weight gain between all vitamin-supplemented groups treated with scopolamine and the vitamin-un supplemented group with scopolamine treatment. No significant difference in brain weight was found be tween the N-Sc group and the Sc group. Among the scopolamine-treated groups, the brain weights of vita min-treated groups did not differ from those of the group treated with scopolamine only. But the brain weights of each vitamin-supplemented group treated with scopolamine was significantly lower than of those in the group not treated with it. Brain acetylcholinesterase activity was markedly re duced by scopolamine injection (Table 4) . However, when vitamin E and/or vitamin C were supplemented in the diet, the reduced enzyme activity was signifi cantly increased to the level of the scopolamine-un treated group (Table 4 ). In the VCE-Sc group, the activ ity was even higher than in the scopolamine-untreated group (Table 4 ). The levels of brain neurotransmitters in each experimental group are presented in Table 5 . There were no significant differences in brain dopamine and norepinephrine concentrations among all five Table 5 . Neurotransmitter levels in the brain for the experimental groups (ng/g wet weight). groups. However, brain serotonin concentration was significantly higher in the VC-Sc group than in the Sc group.
DISCUSSION
In this study, vitamin E and/or vitamin C were added to the diet to investigate their effects on brain acetyl cholinesterase activity and neurotransmitter levels in rats with an administration of scopolamine, which works as a blocking agent of an acetylcholine receptor, leading to dementia. Scopolamine administration re duced body weight but had little effect on brain weight. Moreover, the administration of quite high doses of vita min E and/or vitamin C did not affect these parameters in scopolamine-treated rats as some other vitamin stud ies have already indicated (Table 3) (16, (31) (32) (33) .
In this study, brain acetylcholinesterase activity was markedly reduced by scopolamine injection, and the re duced activity was restored to the original level by sup plementation with vitamin C or vitamin E (Table 4) . Southam et al. (34) and Goss-Sampson et al. (35) re ported that vitamin E deficiency in rats led to the de rangement of acetylcholinesterase transport in the neu rons. Noda et al. (9) also reported that vitamin E defi ciency had significantly reduced acetylcholinesterase activity in the cerebral cortex, hippocampus, and hypo thalamus, as seen in this study. These findings suggest that vitamin E may prevent oxidative stress in the neu rons, as indicated in the study of Vannucchi et al. (36) and Cadenas et al. (37) , and that it is helpful in main taining the function of the cholinergic nervous system. Furthermore, brain acetylcholinesterase activity in the VCE-Sc group was higher than in the N-Sc group. This could suggest that vitamins E and C may have a syner gistic effect and could protect the brain from damage in duced by scopolamine more strongly than each vitamin supplementation. Thus the supplementation of vita mins E and C may be beneficial in the prevention of de mentia.
However, there were no significant differences in dopamine and norepinephrine levels in the brain among all the experimental groups (Table 5 ). Although supplementation with vitamin E and/or vitamin C did not affect the levels of brain neurotransmitters in this study, several other studies have shown that vitamins E and C affect the levels of neurotransmitters in the brain (38, 39) . But brain serotonin level in this study was sig nificantly higher in the VC-Sc group than in the Sc group, though there was no difference in that concen tration between the N-Sc group and the Sc group or be tween the Sc group and the VE-Sc or the VCE-Sc group. We expected that vitamin treatment might improve the brain serotonin level, but a significant difference was observed only in the VC-Sc group. It is very difficult to interpret the result because of the inconsistent out come, which could be a limitation of the in vivo study. Furthermore, no difference in the level between the VCE-Sc group and the Sc group might be due to the ex perimental period of our study being not long enough to observe the effect or that there might be some inter actions between vitamin C and vitamin E on brain sero tonin metabolism.
The result of our study suggests, however, that vita min C may play a certain role in brain serotonin level. Gudelsky (20) examined the effect of vitamin C on the depletion of serotonin in the 5-HT neuron and found that the brain serotonin level did not decrease in rats when MDMA was administered with vitamin C, though the level was reduced by 30-35% in MDMA-treated rats without vitamin C administration. This may be ex plained by the study of Todd and Bauer (40) that vita min C may modulate the serotonergic function by con trolling 5-[3H]-hydroxytryptamine binding to bovine frontal cortex membranes. From the findings of our study and others (20, 40) , it appeared that vitamin C supplementation might have a beneficial effect on pre venting damage to the nervous system. More elaborated studies are needed to investigate the effects of vitamin C or vitamin E supplementation on brain neurotransmit ter metabolism.
In conclusion, the results of the present study indi cate that supplementation with vitamin E and/or vita min C might be useful in maintaining brain acetyl cholinesterase activity at the normal level and sero tonin concentration for some extent after the induction of dementia by scopolamine treatment.
